Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,856,740
  • Shares Outstanding, K 109,866
  • Annual Sales, $ 11,035 M
  • Annual Income, $ 992,000 K
  • EBIT $ 1,710 M
  • EBITDA $ 2,280 M
  • 60-Month Beta 0.65
  • Price/Sales 1.99
  • Price/Cash Flow 13.16
  • Price/Book 3.08

Options Overview Details

View History
  • Implied Volatility 26.50% (+0.08%)
  • Historical Volatility 27.40%
  • IV Percentile 81%
  • IV Rank 42.11%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 3) 4.65 (2.34%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 69
  • Volume Avg (30-Day) 521
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 13,901
  • Open Int (30-Day) 15,516
  • Expected Range 194.29 to 203.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.39
  • Number of Estimates 9
  • High Estimate 2.51
  • Low Estimate 2.25
  • Prior Year 2.21
  • Growth Rate Est. (year over year) +8.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
195.39 +1.82%
on 03/09/26
213.50 -6.82%
on 02/27/26
-7.93 (-3.83%)
since 02/13/26
3-Month
171.18 +16.22%
on 01/05/26
213.50 -6.82%
on 02/27/26
+20.28 (+11.35%)
since 12/16/25
52-Week
157.20 +26.55%
on 04/09/25
213.50 -6.82%
on 02/27/26
+28.78 (+16.91%)
since 03/14/25

Most Recent Stories

More News
Digi Power X Provides Clarification on US Data Centers Transaction

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 198.94 (-0.38%)
DGXX : 2.48 (+11.71%)
Hans Vestberg Co-Founds Next Phase of US Data Centers Inc. with Digi Power X to Deploy Modular AI Infrastructure at Scale

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 198.94 (-0.38%)
DGX.NE : 3.4100 (+11.07%)
DGX.VN : 3.790 (+5.28%)
DGXX : 2.48 (+11.71%)
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

SECAUCUS, N.J. , March 12, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors has...

DGX : 198.94 (-0.38%)
Digi Power X Announces ARMS 200 Commissioning and Timetable for Generating its First AI Revenues

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 198.94 (-0.38%)
DGX.NE : 3.4100 (+11.07%)
DGX.VN : 3.790 (+5.28%)
DGXX : 2.48 (+11.71%)
Digi Power X Graduates to Cboe Canada

Cboe Canada Inc. (“Cboe Canada”) is pleased to announce that Digi Power X Inc. (“Digi Power X” or the “Company”) has graduated from the venture markets and is now listed...

DGX : 198.94 (-0.38%)
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer

Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team

DGX : 198.94 (-0.38%)
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference

SECAUCUS, N.J. , Feb. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief...

DGX : 198.94 (-0.38%)
Do Wall Street Analysts Like Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects.

XLV : 151.01 (+0.81%)
DGX : 198.94 (-0.38%)
$SPX : 6,699.38 (+1.01%)
5 Insightful Analyst Questions From Quest’s Q4 Earnings Call

5 Insightful Analyst Questions From Quest’s Q4 Earnings Call

DGX : 198.94 (-0.38%)
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds

DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds

DGX : 198.94 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 203.94
2nd Resistance Point 202.91
1st Resistance Point 200.93
Last Price 198.94
1st Support Level 197.91
2nd Support Level 196.87
3rd Support Level 194.89

See More

52-Week High 213.50
Last Price 198.94
Fibonacci 61.8% 191.99
Fibonacci 50% 185.35
Fibonacci 38.2% 178.71
52-Week Low 157.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar